Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Laryngeal Diseases × Nimorazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Laryngeal Diseases 1

Interventions

Cisplatin 2 pembrolizumab 1 niraparib 1 dostarlimab 1 Tablets 1 Radiotherapy 1 Nimorazole 1 Combined Modality Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01733823 2017-07-28

DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole

Danish Head and Neck Cancer Group

Phase 1/2 Completed

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡